A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
Washington Cancer Institute is the largest healthcare provider in Maryland and the Washington D.C. region, we serve an enormous population, and their philosophy is to provide knowledge and compassion focused on you, we serve each of our numerous visitors with the attentive care that is a critical part of health and healing.
Washington, District of Columbia Clinical Trial Location
Washington Cancer Institute
110 Irving St NW C2149,
Washington, DC 20010